EFDID: 467884EFD: View Filing

Issuer: Maxim Income Opportunity Fund IV, L.P. (0001955424) - D

Accession: 0001955424-22-000001 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
  • Entity Name:
    Maxim Income Opportunity Fund IV, L.P.
  • Entity Type:
    Limited Partnership
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Within 5 years (2022)
  • Address:
    600 MADISON AVENUE STE 1700
    NEW YORK, NY 10022
  • Persons:
    Related Persons 3
    Edward Martinson
    Executive Officer
    Edward Maxim Capital Partners, LLC
    Promoter 
    The General Partner of the Issuer (the "General Partner")
    Edward Maxim Capital Group, LLC
    Promoter 
    Investment Manager of the Issuer (the "Manager")
EDGAR: Offering Information
  • Accession Date:
    12/07/2022
  • First Sale Date:
  • Offering Amount:
    Indefinite
  • Amount Sold:
    $0
  • Exemptions:
    Section 3(c)(7), Investment Company Act Section 3(c) , Rule 506
  • Security Type(s):
    Pooled Investment Fund
EFD: Current State Notices

Notices found in EFD

Filed:CA, CT, DE, IA, IL, LA, MA, MD, ME, MN, MS, NC, NH, NJ, NY, OH, PA, TX, WA, WI, WY
EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Maxim Income Opportunity Fund IV, L.P./s/ Edward MartinsonEdward MartinsonCEO & COO2022-12-07
Related EDGAR Submissions
Type Edgar Date EFD: Accession
D/A Jan. 28, 2026 467884: 0001955424-26-000001 Maxim Income Opportunity Fund IV, L.P.
Amount Sold: $292,721,927
D/A Jan. 31, 2025 467884: 0001955424-25-000001 Maxim Income Opportunity Fund IV, L.P.
Amount Sold: $176,123,000
D/A Jan. 31, 2024 467884: 0001955424-24-000001 Maxim Income Opportunity Fund IV, L.P.
Amount Sold: $148,773,000
D/A Nov. 20, 2023 467884: 0001955424-23-000001 Maxim Income Opportunity Fund IV, L.P.
Amount Sold: $142,173,000
D Dec. 07, 2022 467884: 0001955424-22-000001 Maxim Income Opportunity Fund IV, L.P.